New Team Bactiguard

Report this content

Good to Great Tennis Academy and Swedish medtech company Bactiguard AB have today announced that they are continuing to strengthen the development of future tennis talent in Sweden by focusing on younger players between 13 to 14 years of age. Together, Good to Great Tennis Academy and Bactiguard have created a new Team Bactiguard consisting of five promising tennis players in Sweden.

The program will continue for at least five years where the players will have Robin Brage and Martin Öhrman as their coaches. Bactiguard’s sponsorship makes it possible for Good to Great Academy’s Team Bactiguard to have access to and train with a complete set of expert tennis, physical performance and medical network. Team Bactiguard players have done well internationally; they can train and compete in a world-class environment. Players from original Team Bactiguard like Elias Ymer, Mikael Ymer, Daniel Windahl and Fred Simonsson have all played and represented Sweden in the Davis Cup.

"We are seeing a very interesting generation of players in the 13 - 14 age range in Sweden who have done extremely well internationally," says Nicklas Kulti, partner at Good to Great Tennis Academy. Kulti further said, "We have a good competition situation in Sweden with this generation which means being able to encourage and motivate each other to achieve great success."

Bactiguard's CEO Christian Kinch has been interested in tennis since his childhood and says:

"The combination of working with some of the world's best tennis players while inspiring other young people to focus on health and sport are the goals of this unique venture. We are very impressed by these young players and want to help them realize their dreams to the fullest.”

Players of Team Bactiguard: 

Isac Strömberg

Born: 2003

Merits:
1st place: Next Generation Cup P15, 2017 (one year younger)        

1st place: Båstad Tennis  P14, 2017

2nd place: Double EM final for Sweden

Arslan Temirhanov

Born: 2003

Merits:            
1st place:  Salk Open P14, 2017

Semi Båstad Tennis P14, 2017

1st place: Final JSM P14, 2016 (one year younger)

Måns Dahlberg

Born:           2003
Merits:              
1st place:  ETA Falköping P14

Semi ETA Zagreb P14

2nd place:  ETA Tyresö P14

Henrik Bladelius

Born:             2004

Merits:           
2nd place:  Salk Open P14, 2017 (one year younger)

1st place: Next Generation Cup P13, 2017

1st place: Salk Open 2016

1st place: JSM inside 2016

1st place: Båstad 2016

1st place: JSM outside 2016

Jeiden Saidizand

Born:             2004

Merits:           
2nd place:  Salk Open P12, 2016

2nd place:  JSM

For further information, please contact:
Nicklas Kulti, partner Good to Great Tennis Academy, nicklas@goodtogreatworld.com, mobile 0708 71 04 22

Christian Kinch, VD Bactiguard, mobile +46 705 466 732

About Good to Great

Good to Great World AB is an independent company that works with the development of tennis players. The vision is to build northern Europe's1 leading tennis center for the development of tennis players. Until the physical center is ready, Good to Great will help clubs, federations and individuals with their tennis initiative from a mobile academy.

Read more at goodtogreatworld.com 

About Bactiguard

Bactiguard is a Swedish medical device company with a mission to save lives. To achieve this mission we develop and supply infection protection solutions which reduce the risk of healthcare associated infections and the use of antibiotics. This way, we save significant costs for healthcare and the society at large. The Bactiguard technology prevents bacterial adhesion and biofilm formation on medical devices. Bactiguard offers the technology through licence agreements and our BIP (Bactiguard Infection Protection) portfolio of products. Through our licence partner CR Bard, urinary catheters with Bactiguard’s coating are market leading in the USA and Japan. Bactiguard’s own product portfolio of urinary catheters, endotracheal tubes and central venous catheters prevent some of the most common infections, which appear in the urinary tract, the blood stream and the respiratory tract.

Bactiguard is in a strong expansion phase in the European markets, China, India and the Middle East as well by establishing license agreements in new therapeutic areas. The company has about 60 employees around the world. Its headquarters and one of two production facilities are located in Stockholm, the other one in Malaysia. Bactiguard is listed on Nasdaq Stockholm.

Read more about how Bactiguard saves lives on www.bactiguard.com